CSS
INTS icon

Cubist Systematic Strategies’s Intensity Therapeutics INTS Stock Holding History

Cubist Systematic Strategies’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-467
Closed -$3.58K – 3256
2025
Q2 		$3.58K Buy
+467
New +$9.6K ﹤0.01% 2862

Other funds holding INTS

SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
SFGP
Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.32B AUM 23.07% 1-Year Est. Return

Cubist Systematic Strategies's INTS Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Intensity Therapeutics (INTS) in Q3 2025, closing a stake of 467 shares — an estimated $3.58K sold.

Cubist Systematic Strategies first reported a position in INTS in Q2 2025 and held it in 1 quarter. The position peaked at $3.58K in Q2 2025. 26 funds tracked by Wall St. Rank hold INTS as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Intensity Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 467 Intensity Therapeutics shares in Q3 2025, an estimated $3.58K.
  • Cubist Systematic Strategies first reported a position in Intensity Therapeutics in Q2 2025 and held it in 1 quarter.
  • Cubist Systematic Strategies's Intensity Therapeutics position peaked at $3.58K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.